We are proud to announce that Jack, our Head of Computational Biology, was featured in this article about his groundbreaking research on childhood neurological diseases.

Jack Welland, a PhD student at St John's, led a study that mapped the molecular structure of the enzyme B4GALNT1, revealing how mutations in this enzyme cause severe neurological disorders in children, including hereditary spastic paraplegia type 26. This condition leads to progressive leg stiffness, spasms, and cognitive impairment.

The research, published in Nature Communications, identified the specific molecular mechanisms behind these life-limiting diseases for the first time. The enzyme B4GALNT1 plays a crucial role in creating complex brain gangliosides - essential components for normal brain function. When the enzyme malfunctions, it causes serious damage to neurons, resulting in loss of limb function and intellectual disability.

We are thrilled to work alongside such brilliant minds like Jack, whose dedication to understanding complex biological mechanisms exemplifies the caliber of talent that drives innovation forward. At Labtree, we are committed to progressing towards making science better by supporting researchers who tackle some of the most challenging questions in medicine and biology. Jack's work represents exactly the kind of impactful research that can transform lives and advance our understanding of human health.